Chreto is developing a novel, cost effective, generic and single use affinity purification technology platform for all biologicals made by the biopharmaceutical industry and plasma fractionation industry. The DAP technology will radically change the cost structure and improve the process efficiencies of downstream processing of large biomolecules.

Chreto is developing a novel, cost effective, generic and single use affinity purification technology platform for all biologicals made by the biopharmaceutical industry and plasma fractionation industry. The DAP technology will radically change the ...Show all